Molecular identification of a renal urate–anion exchanger that regulates blood urate levels

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature

• Publication date

  2002-05-23

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nature742PMID 12024214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two independent mutational events in the loss of urate oxidase during hominoid evolution

  2004cited by this paper
• Handbook of Antioxidants

  2001cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter.

  2001cited by this paper
• Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction.

  2000cited by this paper
• Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta*

  2000cited by this paper
• Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.

  1999cited by this paper
• Mitochondrial Manganese Superoxide Dismutase Prevents Neural Apoptosis and Reduces Ischemic Brain Injury: Suppression of Peroxynitrite Production, Lipid Peroxidation, and Mitochondrial Dysfunction

  1998cited by this paper
• Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis.

  1998cited by this paper
• Regulation of renal urate excretion: a critical review.

  1998cited by this paper
• Organic cation transporters in intestine, kidney, liver, and brain.

  1998cited by this paper
• Cloning and Characterization of a Novel Multispecific Organic Anion Transporter *

  1997cited by this paper
• Expression Cloning and Characterization of ROAT1

  1997cited by this paper
• Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter*

  1997cited by this paper
• The management of gout.

  1996cited by this paper
• Indirect coupling of urate and p-aminohippurate transport to sodium in human brush-border membrane vesicles.

  1996cited by this paper
• Acute renal failure after exercise in a child with renal hypouricemia

  1995cited by this paper
• Drug excretion mediated by a new prototype of polyspecific transporter

  1994cited by this paper
• Urate transport in brush-border membrane of human kidney.

  1994cited by this paper
• Uric acid nephrolithiasis.

  1994cited by this paper
• Acute renal failure after exercise in a child with renal hypouricaemia

  1993cited by this paper
• Towards the physiological function of uric acid.

  1993cited by this paper
• Antioxidants and aging.

  1991cited by this paper
• Uric acid nephrolithiasis.

  1989cited by this paper
• Urate oxidase: primary structure and evolutionary implications.

  1989cited by this paper
• Metabolic substrates, cellular energy production, and the regulation of proximal tubular transport.

  1985cited by this paper
• Single K+-channel current measurements from brain synaptosomes in lipid bilayers.

  1983cited by this paper
• Specificity and modes of the anion exchanger in dog renal microvillus membranes.

  1983cited by this paper
• Mechanism of urate and p-aminohippurate transport in rat renal microvillus membrane vesicles.

  1983cited by this paper
• Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

  1981cited by this paper
• Studies of hyperuricemia produced by pyrazinamide.

  1957cited by this paper
• The renal mechanism for urate excretion in man.

  1950cited by this paper

• Remnant cholesterol: an independent, dose-dependent risk factor for hyperuricemia in a normolipidemic chinese population

  2026cites this paper
• Urate transporters: Structural mechanisms and therapeutic opportunities in drug development

  2026cites this paper
• A Novel Strategy in Managing Spent Probiotic Culture Media: Metabolome Identified Functional Candidates Against Hyperuricemia.

  2026cites this paper
• Renoprotective effects of perennial ryegrass attenuate UA mediated renal damage via modulating gut microbiota and anti-oxidative defense.

  2026cites this paper
• Genome-wide association studies and traditional Chinese medicine in hyperuricemia: current evidence and mechanistic insights

  2026cites this paper
• Changes in uric acid levels and estimated glomerular filtration rate slope after treatment with dotinurad in patients with hyperuricemia.

  2026cites this paper
• SLC52A1 Is a Neofunctionalized Primate Urate Transporter Enabling Intestinal Urate Secretion.

  2026cites this paper
• Additive Association of ABCG2 rs4148155 and SLC22A12 rs75786299 Polymorphisms with Hyperuricemia, Gout, and Nephrolithiasis: A Hospital-Based, Case-Control Study

  2026influential citation
• Chronic kidney disease, hyperuricemia, and gout after adrenalectomy for primary aldosteronism: a 20-year population-based study.

  2025cites this paper
• Hyperuricaemia and metabolic syndrome

  2025cites this paper
• Asymptomatic Hyperuricemia and the Kidney: Lessons from the URRAH Study

  2025cites this paper
• Tigulixostat Alleviates Hyperuricemic Nephropathy by Promoting M2 Macrophage Polarization

  2025cites this paper
• The Long-Term Effects of the Selective Inhibitor of Urate Transporter 1, Dotinurad, on Metabolic Parameters and Renal Function in Japanese Patients With Asymptomatic Hyperuricemia

  2025cites this paper
• Discovery of novel benzomorpholine derivatives as potent URAT1 inhibitors with hypouricemic effects.

  2025cites this paper
• Relationship between changes in uric acid levels and renal function during 12 months of treatment with luseogliflozin

  2025cites this paper
• Case report: Gouty renal abscess and gouty sacroiliitis associated with genetic variants of a young woman

  2025cites this paper
• Therapeutic effect and mechanism of gigantol on hyperuricemia

  2025cites this paper
• Structural similarity-based search for glinides exhibiting cis- and trans-inhibitory activity toward uric acid transporter 1.

  2025cites this paper
• Effect of gout on 30-day survival in ICU patients: retrospective analysis of a large cohort of critically ill patients

  2025cites this paper
• Structural basis of urate transport by glucose transporter 9.

  2025cites this paper
• Prunus mume Alleviates Hyperuricemic Renal Injury: Insights From Network Pharmacology and Experimental Models.

  2025cites this paper
• Benzbromarone Analog SAR: Potent hURAT1 (SLC22A12) Inhibitors and Drug Transporter Interaction Studies

  2025cites this paper
• Effects of Allisartan on Uric Acid, Left Atrial, Left Ventricular, and Artery Stiffness in Mild‐to‐Moderate Essential Hypertension

  2025cites this paper
• The anti-hyperuricemia potential of bioactive natural products and extracts derived from traditional Chinese medicines: A review and perspective

  2025cites this paper
• Therapeutic Potential and Molecular Mechanisms of Natural Compounds for Managing Hyperuricemia

  2025cites this paper
• Hyperuricemia and the nephrocerebral continuum

  2025cites this paper
• Non-Linear Associations Between Serum Vitamin D and Uric Acid in Korean Adults: 2022–2023 KNHANES Data

  2025cites this paper
• Physiological serum uric acid concentrations correlate with arterial stiffness in a sex-dependent manner

  2025cites this paper
• Drug transporters in drug disposition – highlights from the year 2024

  2025cites this paper
• Molecular determinants of selective and high-affinity binding of the scaffold protein PDZK1 to the urate transporter URAT1.

  2025cites this paper
• Genetic and epigenetic contribution of ABCG2 to gout susceptibility: a case-control study

  2025influential citation
• Association between serum uric acid levels and primary aldosteronism

  2025cites this paper
• Comprehensive Treatment of Gout with Traditional Chinese Medicine: A Modern Pathophysiological Perspective

  2025cites this paper
• Evolutionary, genetic, and mechanistic insights into uric acid regulation and sex differences

  2025cites this paper
• Clinical and genetic features of Gitelman syndrome patients with hyperuricemia

  2025cites this paper
• Lemon Water Reduces Serum Urate Levels in Gout Patients and Individuals With Hyperuricemia—A Pilot Study

  2025cites this paper
• Renal hypouricemia is associated with a decreased glomerular filtration rate, but not with cardiovascular events or all-cause mortality: the Shizuoka Study

  2025cites this paper
• Comprehensive Evaluation of the Antihyperuricemic Effect of Red Kidney Bean Anthocyanins and Molecular Screening of the Lead Candidate.

  2025cites this paper
• Association Between TyG‐BMI Index and Hyperuricemia in Adult Women

  2025cites this paper
• GLUT2/SLC2A2 is a bi-directional urate transporter

  2025cites this paper
• Kidney Stones in Children: Causes, Consequences, and Concerns

  2025cites this paper
• Changes in Uric Acid Levels and Effects on Renal Function After Switching From Febuxostat to Dotinurad in Patients With Chronic Kidney Disease: A Retrospective Study

  2025cites this paper
• Litiasis úrica

  2025cites this paper
• Structural Basis for Inhibition of Urate Reabsorption in URAT1

  2025cites this paper
• Gene-environment interaction modifies the association between hyperinsulinemia and serum urate levels through SLC22A12

  2025cites this paper
• Genetic Background of Selected Hyperuricemia Causing Gout with Pediatric Onset.

  2025cites this paper
• Switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, may substantially reduce serum urate levels, through URAT1 inhibition, potentially without adversely affecting ABCG2 function: findings from the SWITCH SURI study

  2025cites this paper
• Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter

  2025cites this paper
• Development of a fluorescence-based assay for screening of urate transporter 1 inhibitors (II): Optimization of fluorescent substrates and structure-activity relationships analysis.

  2025cites this paper
• Lychee Peel Extract Ameliorates Hyperuricemia by Regulating Uric Acid Production and Excretion in Mice

  2025cites this paper
• The effect of intensive resistance exercise and excessive fructose intake on metabolic and physiological responses

  2025cites this paper
• Investigation of the potential application of kaemperide in hyperuricemia based on a kidney-on-a-chip.

  2025cites this paper
• Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study

  2025cites this paper
• Molecular basis of the urate transporter URAT1 inhibition by gout drugs

  2025cites this paper
• Renal Nicotinate Handling by Urate Transporter 1

  2025cites this paper
• Revisiting brown adipose tissue whitening: Physiological mechanisms and pathophysiological consequences

  2025cites this paper
• Phytotherapeutic insights into hyperuricemia: a mechanistic and clinical perspective

  2025cites this paper
• Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel

  2025cites this paper
• Molecular mechanisms of urate transport by the native human URAT1 and its inhibition by anti-gout drugs

  2025cites this paper
• Understanding Renal Tubular Function: Key Mechanisms, Clinical Relevance, and Comprehensive Urine Assessment

  2025cites this paper
• Molecular mechanism of drug inhibition of URAT1

  2025influential citation
• Gout management: Patent analytics and computational drug design explores URAT1 inhibitors landscape

  2025cites this paper
• Advances in Traditional Chinese Medicine for the treatment of hyperuricemia and associated diseases: pathogenesis, mechanisms, and future directions

  2025cites this paper
• Incidence and risk of nephrolithiasis with uricosuric therapies for the treatment of gout: a systematic review and meta-analysis of randomised controlled trials and cohort studies.

  2025cites this paper
• Monascus Yellow Pigments Ameliorate Hyperuricemia via Dual Mechanisms: Xanthine Oxidase Inhibition and Uric Acid Transporter Modulation (ABCG2, URAT1, and GLUT9)

  2025cites this paper
• Investigation of the Inhibitory Effects of Fatty Acid Derivatives on URAT1 Function, a Renal Urate Re-Absorber.

  2025cites this paper
• Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairment

  2025cites this paper
• Advances in drug delivery systems for the management of gout and hyperuricemia

  2025cites this paper
• Lactobacillus paracasei N1115 alleviates hyperuricemia in mice: regulation of uric acid metabolism as well as its impact on gut microbiota and short-chain fatty acids

  2025cites this paper
• Antihyperuricemic Effects of Cornus officinalis Extract via URAT1 Regulation and Renoprotective Mechanisms

  2025influential citation
• Benzbromarone improves blood hypercoagulability after TBI by reducing phosphatidylserine externalization through inhibition of TMEM16F expression.

  2025cites this paper
• Prevalence and associated factors of hyperuricemia in chronic kidney disease: evidence from a single-center hospital-based study in Ethiopia, 2024

  2025cites this paper
• Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions.

  2024cites this paper
• Safety and Efficacy of Dotinurad on Uric Acid in Patients With Chronic Kidney Disease With Estimated Glomerular Filtration Rate Below 25 mL/Min/1.73 m².

  2024cites this paper
• Hypouricemia with hypercalciuria: Longitudinal study and review of the topic.

  2024cites this paper
• Genetic and epigenetic dysregulation of innate immune mechanisms in autoinflammatory diseases

  2024cites this paper
• Virtual screening and biological evaluation of natural products as urate transporter 1 (URAT1) inhibitors

  2024cites this paper
• Review of childhood genetic nephrolithiasis and nephrocalcinosis

  2024cites this paper
• The potential role of uric acid in women with polycystic ovary syndrome

  2024cites this paper
• Gout Management Using Nanocarrier Systems: A Review

  2024cites this paper
• Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout

  2024cites this paper
• Plasma and Urinary Metabolomic Analysis of Gout and Asymptomatic Hyperuricemia and Profiling of Potential Biomarkers: A Pilot Study

  2024cites this paper
• Effects of allisartan‐isoproxil‐based combination antihypertensive regimen in hypertensive patients with microalbuminuria or hyperuricemia

  2024cites this paper
• Hyperuricemia: An Intriguing Connection to Metabolic Syndrome, Diabetes, Kidney Disease, and Hypertension

  2024influential citation
• Unique Binding Sites of Uricosuric Agent Dotinurad for Selective Inhibition of Renal Uric Acid Reabsorptive Transporter URAT1

  2024cites this paper
• Uric acid in health and disease: From physiological function to pathogenic mechanism.

  2024cites this paper
• A System for Discovering Novel Uricosurics Targeting Urate Transporter 1 Based on In Vitro and In Vivo Modeling

  2024cites this paper
• A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease

  2024cites this paper
• Chinese Sumac (Rhus chinensis Mill.) Fruits Prevent Hyperuricemia and Uric Acid Nephropathy in Mice Fed a High-Purine Yeast Diet

  2024cites this paper
• Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout

  2024cites this paper
• Treatment of hyperuricaemia and gout with probiotics and gut flora

  2024cites this paper
• Lithiase urique

  2024cites this paper
• Functional characteristics of equilibrative nucleoside transporter 2 (ENT2/SLC29A2) for the transport of urate as a newly identified substrate.

  2024cites this paper
• Uric acid in diabetic microvascular complications: Mechanisms and therapy.

  2024cites this paper
• Identification of N-phenyl-N-(quinolin-4-yl) amino carboxylic acids as URAT1 inhibitors with hypouricemic effects.

  2024cites this paper
• In vitro colonic fermentation of fermented Radix Astragali by Poria cocos and anti-hyperuricemia mechanism based on network pharmacology and experiment verification

  2024cites this paper
• Establishment and optimization of a novel mouse model of hyperuricemic nephropathy

  2024cites this paper
• Establishment of Polydopamine-Modified HK-2 Cell Membrane Chromatography and Screening of Active Components from Plantago asiatica L.

  2024cites this paper
• Progress in the clinical effects and adverse reactions of ticagrelor

  2024cites this paper
• A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

  2024cites this paper